Quantification of [11C]FLB 457 Binding to Extrastriatal Dopamine Receptors in the Human Brain
Positron emission tomography (PET) has hitherto been used to examine D2 dopamine receptor binding in the striatum, a region with a high density of receptors. Research has been hampered by the lack of suitable radioligands for detection of the low-density D2 dopamine receptor populations in the limbi...
Saved in:
Published in | Journal of cerebral blood flow and metabolism Vol. 19; no. 10; pp. 1164 - 1173 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
London, England
SAGE Publications
01.10.1999
Lippincott Williams & Wilkins |
Subjects | |
Online Access | Get full text |
ISSN | 0271-678X 1559-7016 |
DOI | 10.1097/00004647-199910000-00013 |
Cover
Abstract | Positron emission tomography (PET) has hitherto been used to examine D2 dopamine receptor binding in the striatum, a region with a high density of receptors. Research has been hampered by the lack of suitable radioligands for detection of the low-density D2 dopamine receptor populations in the limbic and cortical dopamine systems that are implicated in the patophysiology of schizophrenia. [11C]FLB 457 is a new radioligand with the very high affinity of 20 pmol/L (Ki) for the D2 and D3 dopamine receptor subtypes. This study in eight healthy subjects was designed to evaluate the suitability of [11C]FLB 457 for quantification of extrastriatal D2/D3 dopamine receptors. PET-data were acquired in the three-dimensional mode and the arterial input function was corrected for labeled metabolites. The standard three-compartment model and four derived approaches were applied to calculate and compare the binding potentials. Besides the striatum, conspicuous radioactivity was found in extrastriatal regions such as the thalamus, the anterior cinguli, and the temporal and frontal cortices. The time activity curves could be described by the three compartment model. The different approaches gave similar binding potential values and the rank order between regions was consistent with that found in vitro. The short time of a PET measurement using [11C]FLB 457 (63 minutes) seemed not to be sufficient for reliable determination of the high binding potential in the striatum. These results are of principal importance because they show the potential for PET quantification of minute receptor populations in the human brain. |
---|---|
AbstractList | Positron emission tomography (PET) has hitherto been used to examine D2 dopamine receptor binding in the striatum, a region with a high density of receptors. Research has been hampered by the lack of suitable radioligands for detection of the low-density D2 dopamine receptor populations in the limbic and cortical dopamine systems that are implicated in the pathophysiology of schizophrenia. [11C]FLB 457 is a new radioligand with the very high affinity of 20 pmol/L (K(i)) for the D2 and D3 dopamine receptor subtypes. This study in eight healthy subjects was designed to evaluate the suitability of [11C]FLB 457 for quantification of extrastriatal D2/D3 dopamine receptors. PET-data were acquired in the three-dimensional mode and the arterial input function was corrected for labeled metabolites. The standard three-compartment model and four derived approaches were applied to calculate and compare the binding potentials. Besides the striatum, conspicuous radioactivity was found in extrastriatal regions such as the thalamus, the anterior cinguli, and the temporal and frontal cortices. The time activity curves could be described by the three compartment model. The different approaches gave similar binding potential values and the rank order between regions was consistent with that found in vitro. The short time of a PET measurement using [11C]FLB 457 (63 minutes) seemed not to be sufficient for reliable determination of the high binding potential in the striatum. These results are of principal importance because they show the potential for PET quantification of minute receptor populations in the human brain. Positron emission tomography (PET) has hitherto been used to examine D2 dopamine receptor binding in the striatum, a region with a high density of receptors. Research has been hampered by the lack of suitable radioligands for detection of the low-density D2 dopamine receptor populations in the limbic and cortical dopamine systems that are implicated in the patophysiology of schizophrenia. [ 11 C]FLB 457 is a new radioligand with the very high affinity of 20 pmol/L (K i ) for the D2 and D3 dopamine receptor subtypes. This study in eight healthy subjects was designed to evaluate the suitability of [ 11 C]FLB 457 for quantification of extrastriatal D2/D3 dopamine receptors. PET-data were acquired in the three-dimensional mode and the arterial input function was corrected for labeled metabolites. The standard three-compartment model and four derived approaches were applied to calculate and compare the binding potentials. Besides the striatum, conspicuous radioactivity was found in extrastriatal regions such as the thalamus, the anterior cinguli, and the temporal and frontal cortices. The time activity curves could be described by the three compartment model. The different approaches gave similar binding potential values and the rank order between regions was consistent with that found in vitro. The short time of a PET measurement using [ 11 C]FLB 457 (63 minutes) seemed not to be sufficient for reliable determination of the high binding potential in the striatum. These results are of principal importance because they show the potential for PET quantification of minute receptor populations in the human brain. Positron emission tomography (PET) has hitherto been used to examine D2 dopamine receptor binding in the striatum, a region with a high density of receptors. Research has been hampered by the lack of suitable radioligands for detection of the low-density D2 dopamine receptor populations in the limbic and cortical dopamine systems that are implicated in the patophysiology of schizophrenia. [11C]FLB 457 is a new radioligand with the very high affinity of 20 pmol/L (Ki) for the D2 and D3 dopamine receptor subtypes. This study in eight healthy subjects was designed to evaluate the suitability of [11C]FLB 457 for quantification of extrastriatal D2/D3 dopamine receptors. PET-data were acquired in the three-dimensional mode and the arterial input function was corrected for labeled metabolites. The standard three-compartment model and four derived approaches were applied to calculate and compare the binding potentials. Besides the striatum, conspicuous radioactivity was found in extrastriatal regions such as the thalamus, the anterior cinguli, and the temporal and frontal cortices. The time activity curves could be described by the three compartment model. The different approaches gave similar binding potential values and the rank order between regions was consistent with that found in vitro. The short time of a PET measurement using [11C]FLB 457 (63 minutes) seemed not to be sufficient for reliable determination of the high binding potential in the striatum. These results are of principal importance because they show the potential for PET quantification of minute receptor populations in the human brain. |
Author | Swahn, Carl-Gunnar Halldin, Christer Olsson, Hans Farde, Lars |
Author_xml | – sequence: 1 givenname: Hans surname: Olsson fullname: Olsson, Hans organization: Karolinska Institutet, Department of Clinical Neuroscience, Psychiatry Section, Stockholm, Sweden – sequence: 2 givenname: Christer surname: Halldin fullname: Halldin, Christer organization: Karolinska Institutet, Department of Clinical Neuroscience, Psychiatry Section, Stockholm, Sweden – sequence: 3 givenname: Carl-Gunnar surname: Swahn fullname: Swahn, Carl-Gunnar organization: Karolinska Institutet, Department of Clinical Neuroscience, Psychiatry Section, Stockholm, Sweden – sequence: 4 givenname: Lars surname: Farde fullname: Farde, Lars organization: Karolinska Institutet, Department of Clinical Neuroscience, Psychiatry Section, Stockholm, Sweden |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1962093$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/10532641$$D View this record in MEDLINE/PubMed http://kipublications.ki.se/Default.aspx?queryparsed=id:1927724$$DView record from Swedish Publication Index |
BookMark | eNqFkV1LBCEUhiWK2j7-QnjR7ZTO6DjeBO22fcBCFF0EEXLGccra1UVdqn-ftVtBNwniUZ_zou-7jdaddwYhTMkhJVIckTxYzURBpZT0c1fkSas1NKCcy0IQWq-jASkFLWrR3G2h7RifM9JUnG-iLUp4VdaMDtDD9QJcsr3VkKx32Pf4ntLRw9lkiBkXeGhdZ90jTh6P31KAmIKFBFN86ucws87gG6PNPPkQsXU4PRl8sZiBw8MA1u2ijR6m0eyt1h10eza-HV0Uk6vzy9HJpNCMy1RwMD3lhLWt7JgAKTkroSyFlK3ojKDQazAMakmasjMt6aoO2rZrel3ShuhqBxVL2fhq5otWzYOdQXhXHqxaHb3kyqiaVE0tMr-_5PPNzHQ__LctGThYARA1TPsATtv4y8m6JLLK2PES08HHGEyvtE1fPman7DTrqc-41Hdc6icu9RVXFmj-CPw-5d9WvvozPBr17BfBZYf_7_sAJ5WmoQ |
CODEN | JCBMDN |
CitedBy_id | crossref_primary_10_1016_j_neuroimage_2009_12_006 crossref_primary_10_1176_appi_ajp_158_2_308 crossref_primary_10_1016_j_schres_2010_03_043 crossref_primary_10_1016_j_neuroimage_2008_05_056 crossref_primary_10_1017_S1461145707008358 crossref_primary_10_1111_adb_12812 crossref_primary_10_1016_j_biopsych_2004_11_009 crossref_primary_10_1097_00006231_200503000_00011 crossref_primary_10_1371_journal_pone_0023298 crossref_primary_10_1523_JNEUROSCI_3446_08_2008 crossref_primary_10_1046_j_1471_4159_2002_00895_x crossref_primary_10_1016_j_bmc_2005_06_055 crossref_primary_10_1016_j_schres_2018_10_008 crossref_primary_10_1002_syn_20765 crossref_primary_10_1016_j_neulet_2018_03_006 crossref_primary_10_1109_23_940161 crossref_primary_10_1093_schbul_sby076 crossref_primary_10_1016_j_pscychresns_2011_01_011 crossref_primary_10_1016_S1053_8119_03_00166_6 crossref_primary_10_1371_journal_pone_0006725 crossref_primary_10_1007_s12149_007_0083_2 crossref_primary_10_1007_s00213_005_0092_6 crossref_primary_10_1523_JNEUROSCI_2097_04_2005 crossref_primary_10_1002_syn_20806 crossref_primary_10_1016_j_nucmedbio_2010_04_138 crossref_primary_10_1002_syn_20926 crossref_primary_10_1016_S0304_3940_01_01552_X crossref_primary_10_1176_ajp_2007_164_4_630 crossref_primary_10_1002_1099_1344_20001015_43_11_1069__AID_JLCR390_3_0_CO_2_N crossref_primary_10_1212_WNL_54_7_1482 crossref_primary_10_3390_ijms23042005 crossref_primary_10_1016_j_neuroimage_2012_11_045 crossref_primary_10_1073_pnas_0911805107 crossref_primary_10_1111_j_1460_9568_2004_03622_x crossref_primary_10_1038_jcbfm_2014_237 crossref_primary_10_1002_syn_20813 crossref_primary_10_1021_cr0782426 crossref_primary_10_1371_journal_pone_0017723 crossref_primary_10_1007_s12264_024_01188_0 crossref_primary_10_1016_j_neuroimage_2004_02_002 crossref_primary_10_1038_tp_2012_40 crossref_primary_10_1093_brain_awt337 crossref_primary_10_1006_phrs_2000_0782 crossref_primary_10_1016_j_nucmedbio_2007_09_009 crossref_primary_10_1097_00004647_200112000_00014 crossref_primary_10_1177_0271678X19874770 crossref_primary_10_2310_7290_2013_00065 crossref_primary_10_1006_nimg_2000_0717 crossref_primary_10_1097_MNM_0b013e328356fbc3 crossref_primary_10_1002_syn_20062 crossref_primary_10_1111_j_1755_5949_2010_00222_x crossref_primary_10_1007_s12149_019_01405_1 crossref_primary_10_1016_j_icrp_2008_08_005 crossref_primary_10_1016_j_icrp_2008_08_007 crossref_primary_10_1097_00006231_200111000_00008 crossref_primary_10_1523_JNEUROSCI_3933_10_2010 crossref_primary_10_1002_syn_20628 crossref_primary_10_1006_nimg_2001_0879 crossref_primary_10_1016_S0969_8051_00_00154_2 crossref_primary_10_1016_j_pscychresns_2009_04_006 crossref_primary_10_1002_syn_21566 crossref_primary_10_1006_nimg_2001_0761 crossref_primary_10_1007_s12194_015_0343_0 crossref_primary_10_1080_09540261_2017_1398139 crossref_primary_10_1017_S1461145708009577 crossref_primary_10_1371_journal_pone_0049483 crossref_primary_10_3390_ijms22041719 crossref_primary_10_1016_S0006_3223_02_01602_5 crossref_primary_10_1038_sj_npp_1301242 crossref_primary_10_1016_j_apradiso_2008_05_010 crossref_primary_10_1016_j_neuroimage_2009_07_021 crossref_primary_10_1155_2013_627496 crossref_primary_10_1002_jnr_24779 crossref_primary_10_1007_s12149_010_0407_5 crossref_primary_10_1097_00004714_200302000_00002 crossref_primary_10_1016_j_pain_2004_01_013 crossref_primary_10_1038_s41380_020_00934_w crossref_primary_10_1016_j_neuroimage_2009_02_031 crossref_primary_10_1016_j_jad_2006_11_010 crossref_primary_10_1007_s00259_008_0969_9 crossref_primary_10_1038_sj_jcbfm_9600339 crossref_primary_10_1016_j_euroneuro_2019_06_004 crossref_primary_10_1038_sj_npp_1301108 crossref_primary_10_1016_j_biopsych_2022_05_009 crossref_primary_10_1038_jcbfm_2009_270 crossref_primary_10_1038_sj_jcbfm_9600340 crossref_primary_10_1021_acsmedchemlett_8b00504 crossref_primary_10_1523_JNEUROSCI_5689_09_2010 crossref_primary_10_1038_jcbfm_2014_150 crossref_primary_10_2967_jnumed_108_058503 crossref_primary_10_1038_jcbfm_2013_55 crossref_primary_10_2310_7290_2015_00006 crossref_primary_10_1007_s00213_004_1830_x crossref_primary_10_1016_j_neuroimage_2006_02_053 crossref_primary_10_1016_j_neuroimage_2020_117523 crossref_primary_10_1002_1098_2396_200011_38_2_138__AID_SYN4_3_0_CO_2_7 crossref_primary_10_1053_j_semnuclmed_2015_09_003 crossref_primary_10_1016_j_neuroimage_2010_02_006 crossref_primary_10_1124_jpet_106_109173 crossref_primary_10_1007_s00259_005_0027_9 crossref_primary_10_1016_j_nbd_2012_06_021 crossref_primary_10_1017_S1461145707008103 crossref_primary_10_1016_j_drugalcdep_2016_01_029 crossref_primary_10_1038_npp_2009_88 crossref_primary_10_1016_j_neuroimage_2006_11_008 crossref_primary_10_1016_j_pnpbp_2005_06_011 crossref_primary_10_1176_appi_ajp_158_6_926 crossref_primary_10_1371_journal_pone_0010670 crossref_primary_10_1016_S0304_3959_02_00121_5 crossref_primary_10_1093_brain_awy133 crossref_primary_10_1371_journal_pone_0076905 crossref_primary_10_1038_sj_npp_1300916 crossref_primary_10_2967_jnumed_111_094029 crossref_primary_10_1523_JNEUROSCI_1037_23_2023 crossref_primary_10_1007_s11682_017_9779_7 |
Cites_doi | 10.1007/s002130050131 10.1111/j.2042-7158.1973.tb10025.x 10.1002/(SICI)1098-2396(199606)23:2<115::AID-SYN7>3.0.CO;2-C 10.1097/00004647-199601000-00005 10.1097/00002826-199201001-00296 10.1002/syn.890190103 10.1002/syn.890200303 10.1007/978-94-011-0429-6_5 10.1002/ana.410150302 10.1073/pnas.91.23.11271 10.1002/ana.410060502 10.1016/0969-8051(96)00078-9 10.1016/0006-8993(93)90878-Q 10.1038/jcbfm.1986.27 10.1126/science.6604315 10.1007/BF02244067 10.1016/0306-4522(95)00357-6 10.1038/jcbfm.1989.98 10.1109/TAC.1974.1100705 10.1073/pnas.86.16.6412 10.1016/0169-328X(93)90188-U 10.1097/00004728-198102000-00027 10.1016/S0006-8993(97)01078-0 10.1007/s002130050420 10.1038/jcbfm.1990.127 10.1016/S0166-2236(84)80013-2 10.1214/aos/1176344136 10.1016/S0893-133X(98)00066-9 10.1073/pnas.82.11.3863 10.1109/23.12815 10.1006/nimg.1996.0066 10.1097/00004728-199401000-00023 10.1038/385590a0 10.1176/ajp.148.11.1474 10.1038/385634a0 10.1038/sj.npp.1380111 10.1038/347146a0 10.1016/0006-8993(91)91456-B 10.1016/0014-2999(76)90311-3 10.1038/386830a0 |
ContentType | Journal Article |
Copyright | 1999 The International Society for Cerebral Blood Flow and Metabolism 1999 INIST-CNRS |
Copyright_xml | – notice: 1999 The International Society for Cerebral Blood Flow and Metabolism – notice: 1999 INIST-CNRS |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM ADTPV AOWAS |
DOI | 10.1097/00004647-199910000-00013 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed SwePub SwePub Articles |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology Chemistry |
EISSN | 1559-7016 |
EndPage | 1173 |
ExternalDocumentID | oai_swepub_ki_se_603867 10532641 1962093 10_1097_00004647_199910000_00013 10.1097_00004647-199910000-00013 |
Genre | Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S Journal Article |
GrantInformation_xml | – fundername: PHS HHS grantid: R0-41205 |
GroupedDBID | --- -Q- -TM .55 .GJ 0R~ 29K 2WC 36B 39C 3O- 4.4 53G 54M 5GY 5RE 5VS 70F 7X7 88E 8AO 8FE 8FH 8FI 8FJ 8R4 8R5 AABMB AACKU AACMV AADUE AAEWN AAGGD AAGMC AAJIQ AAJPV AAKGS AANSI AAPEO AAQGT AAQXH AAQXI AARDL AARIX AATAA AATBZ AAUAS AAVDI AAXOT AAYTG AAZBJ ABAWP ABAWZ ABCCA ABCJG ABDWY ABEIX ABFWQ ABHKI ABJNI ABJZC ABKRH ABLUO ABNCE ABPGX ABPNF ABQKF ABQNX ABQXT ABRHV ABUJY ABUWG ABVFX ABXGC ABYTW ACARO ACDSZ ACDXX ACFEJ ACFMA ACGBL ACGFO ACGFS ACGZU ACJER ACJTF ACLFY ACLHI ACNXM ACOFE ACOXC ACPRK ACROE ACSIQ ACUAV ACUIR ACXKE ACXMB ADBBV ADEBD ADEIA ADMPF ADNON ADRRZ ADTBJ ADUKL ADVBO ADZZY AECGH AENEX AEPTA AEQLS AESZF AEUHG AEWDL AEWHI AEXFG AEXNY AFEET AFFNX AFFZS AFKRA AFKRG AFMOU AFOSN AFQAA AFUIA AFVCE AGHKR AGKLV AGNHF AGPXR AGWFA AHDMH AHMBA AIGRN AJABX AJEFB AJMMQ AJSCY AJUZI AJXAJ AJXGE ALIPV ALKWR ALMA_UNASSIGNED_HOLDINGS AMCVQ ANDLU AOIJS ARTOV AUTPY AYAKG B8M BAWUL BBNVY BBRGL BDDNI BENPR BHPHI BKIIM BKSCU BPACV BPHCQ BSEHC BVXVI BWJAD C45 CAG CBRKF CCPQU CDWPY CFDXU COF CORYS CQQTX CS3 CUTAK D-I DC- DC. DIK DOPDO DV7 E3Z EBS EE. EJD EMOBN F5P FHBDP FYUFA GROUPED_SAGE_PREMIER_JOURNAL_COLLECTION GX1 H13 HCIFZ HMCUK HYE HZ~ J8X JSO K.F KQ8 LK8 M1P M7P O9- OK1 OVD P2P P6G PHGZM PHGZT PQQKQ PROAC PSQYO Q1R Q2X RNS RNTTT ROL RPM SASJQ SAUOL SCNPE SFC SHG SPQ SPV TEORI TR2 UKHRP W2D X7M YFH YOC ZGI ZONMY ZPPRI ZRKOI ZSSAH ZXP AAYXX AJGYC CITATION AAEJI AAPII AJVBE IQODW PJZUB PPXIY PQGLB 3V. 88A AAMGE ACTQU AEUIJ AIOMO ALTZF CGR CUY CVF ECM EIF M0L M4V NPM ADTPV AJHME AOWAS PUEGO |
ID | FETCH-LOGICAL-c459t-5aef1504bb9d47a99542a22799b7de71afcae4a69082deb0d3dabbd8fc2180c3 |
ISSN | 0271-678X |
IngestDate | Mon Sep 01 03:35:20 EDT 2025 Wed Feb 19 01:35:21 EST 2025 Mon Jul 21 09:14:13 EDT 2025 Tue Jul 01 05:24:55 EDT 2025 Thu Apr 24 23:05:27 EDT 2025 Tue Jun 17 22:35:07 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 10 |
Keywords | Human [11C]FLB 457 Positron emission tomography D2 dopamine receptors Compartment analysis Extrastriatal Radionuclide study Compartmental model D2 Dopamine receptor Central nervous system Exploration Brain (vertebrata) Positron Emission tomography |
Language | English |
License | https://journals.sagepub.com/page/policies/text-and-data-mining-license CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c459t-5aef1504bb9d47a99542a22799b7de71afcae4a69082deb0d3dabbd8fc2180c3 |
PMID | 10532641 |
PageCount | 10 |
ParticipantIDs | swepub_primary_oai_swepub_ki_se_603867 pubmed_primary_10532641 pascalfrancis_primary_1962093 crossref_citationtrail_10_1097_00004647_199910000_00013 crossref_primary_10_1097_00004647_199910000_00013 sage_journals_10_1097_00004647_199910000_00013 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 1900 |
PublicationDate | 1999-10-01 |
PublicationDateYYYYMMDD | 1999-10-01 |
PublicationDate_xml | – month: 10 year: 1999 text: 1999-10-01 day: 01 |
PublicationDecade | 1990 |
PublicationPlace | London, England |
PublicationPlace_xml | – name: London, England – name: Hagerstown, MD – name: United States |
PublicationTitle | Journal of cerebral blood flow and metabolism |
PublicationTitleAlternate | J Cereb Blood Flow Metab |
PublicationYear | 1999 |
Publisher | SAGE Publications Lippincott Williams & Wilkins |
Publisher_xml | – name: SAGE Publications – name: Lippincott Williams & Wilkins |
References | Gurevich, Joyce 1999; 20 Yosef, Volkow, Schlyer, Fowler, Wolf, Wang, Smith, Brodie, Warner 1995; 19 Mintun, Raichle, Kilbourn, Wooten, Welch 1984; 15 Halldin, Farde, Hogberg, Mohell, Hall, Suhara, Karlsson, Nakashima, Swahn 1995a; 36 Kuikka, Åkerman, Hiltunen, Bergström, Räsänen, Vanninen, Halldin, Tiihonen 1997; 24 Logan, Fowler, Volkow, Wolf, Dewey, Schlyer, MacGregor, Hitzemann, Bendriem, Gatley, Christman 1990; 10 Wienhard, Dahlbom, Eriksson, Michel, Bruckbauer, Pietrzyk, Heiss 1994; 18 Fibiger 1994; 55 Bouthenet, Souil, Martres, Sokoloff, Giros, Schwartz 1991; 564 Davis, Kahn, Ko, Davidson 1991; 148 Farde, Suhara, Nyberg, Karlsson, Nakashima, Hietala, Halldin 1997b; 133 Okubo, Suhara, Suzuki, Kobayashi, Inoue, Terasaki, Someya, Sassa, Sudo, Matsushima, Iyo, Tateno, Toru 1997; 385 Sokoloff, Giros, Martres, Bouthenet, Schwartz 1990; 357 Loc'h, Halldin, Bottlaender, Swahn, Moresco, Mazière, Farde, Mazière 1996; 23 Volkow, Wang, Fowler, Logan, Gatley, Hitzemann, Chen, Dewey, Pappas 1997; 386 Lammertsma, Hume 1996; 4 Andén, Stock 1973; 25 Eriksson, Holte, Bohm, Kesselberg, Hovander 1988; 35 Landwehrmeyer, Mengod, Palacios 1993; 18 Lammertsma, Bench, Hume, Osman, Gunn, Brooks, Frackowiak 1996; 16 Farde, Eriksson, Blomquist, Halldin 1989; 9 Murray, Ryoo, Gurevich, Joyce 1994; 91 Phelps, Huang, Hoffman, Selin, Sokoloff, Kuhl 1979; 6 Wagner, Burns, Dannals, Wong, Lågström, Duelfer, Frost, Ravert, Links, Rosenbloom, Lukas, Kramer, Kuhar 1983; 221 Farde, Ehrin, Eriksson, Greitz, Hall, Hedstrom, Litton, Sedvall 1985; 82 Kessler, Whetsell, Ansari, Votaw, De Paulis, Clanton, Schmidt, Mason, Manning 1993; 609 Farde, Gustavsson, Jönsson 1997a; 385 Hall, Farde, Halldin, Hurd, Pauli, Sedvall 1996a; 23 Wong, Gjedde, Wagner 1986; 6 Deutch, Duman 1996; 70 Lidow, Goldman-Rakic, Rakic, Innis 1989; 86 Costall, Naylor 1976; 35 Weinberger, Berman, Daniel 1992; 15 Schwartz 1978; 6 Swahn, Halldin, Lundkvist, Olsson, Karlsson, Farde 1997; 40 Hall, Högberg, Halldin, Köhler, Ström, Ross, Larsson, Farde 1991; 103 Suzuki, Hurd, Sokoloff, Schwartz, Sedvall 1998; 779 Farde, Hall, Pauli, Halldin 1995; 20 Bergström, Boëthius, Eriksson, Greitz, Ribbe, Widén 1981; 5 Nakashima, Farde 1995; 15 Hall, Sedvall, Magnusson, Kopp, Halldin, Farde 1994; 11 Hall, Halldin, Dijkstra, Wikström, Wise, Pugsley, Sokoloff, Pauli, Farde, Sedvall 1996b; 128 Akaike 1974; 19 Janowsky, Neve, Kinzie, Taylor, de Paulis, Belknap 1992; 261 Stevens 1991; 55 bibr3-00004647-199910000-00013 bibr13-00004647-199910000-00013 bibr39-00004647-199910000-00013 bibr42-00004647-199910000-00013 bibr30-00004647-199910000-00013 bibr27-00004647-199910000-00013 bibr44-00004647-199910000-00013 bibr32-00004647-199910000-00013 bibr5-00004647-199910000-00013 Kuikka J (bibr25-00004647-199910000-00013) 1997; 24 bibr18-00004647-199910000-00013 bibr19-00004647-199910000-00013 bibr17-00004647-199910000-00013 Fibiger HC (bibr15-00004647-199910000-00013) 1994; 55 Nakashima Y (bibr35-00004647-199910000-00013) 1995; 15 bibr1-00004647-199910000-00013 bibr40-00004647-199910000-00013 bibr12-00004647-199910000-00013 bibr2-00004647-199910000-00013 bibr4-00004647-199910000-00013 Janowsky A (bibr23-00004647-199910000-00013) 1992; 261 bibr14-00004647-199910000-00013 bibr26-00004647-199910000-00013 bibr38-00004647-199910000-00013 bibr16-00004647-199910000-00013 Swahn C (bibr43-00004647-199910000-00013) 1997; 40 bibr31-00004647-199910000-00013 bibr6-00004647-199910000-00013 Leenders K (bibr29-00004647-199910000-00013) 1997 bibr28-00004647-199910000-00013 bibr20-00004647-199910000-00013 bibr8-00004647-199910000-00013 bibr45-00004647-199910000-00013 bibr33-00004647-199910000-00013 bibr47-00004647-199910000-00013 bibr22-00004647-199910000-00013 bibr46-00004647-199910000-00013 bibr7-00004647-199910000-00013 bibr34-00004647-199910000-00013 bibr10-00004647-199910000-00013 Stevens JR (bibr41-00004647-199910000-00013) 1991; 55 bibr48-00004647-199910000-00013 bibr49-00004647-199910000-00013 Halldin C (bibr21-00004647-199910000-00013) 1995; 36 bibr37-00004647-199910000-00013 bibr24-00004647-199910000-00013 bibr11-00004647-199910000-00013 bibr9-00004647-199910000-00013 bibr36-00004647-199910000-00013 |
References_xml | – volume: 24 start-page: 483 year: 1997 end-page: 487 article-title: Striatal and extrastriatal imaging of dopamine D2 receptors in the living human brain with [123I]epidepride single-photon emission tomography publication-title: Eur J Nucl Med – volume: 148 start-page: 1474 year: 1991 end-page: 1486 article-title: Dopamine in schizophrenia: a review and reconceptualization publication-title: Am J Psychiatry – volume: 70 start-page: 377 year: 1996 end-page: 389 article-title: The effects of antipsychotic drugs on Fos protein expression in the prefrontal cortex: cellular localization and pharmacological characterization publication-title: Neuroscience – volume: 25 start-page: 346 year: 1973 article-title: Effect of clozapine on the turnover of dopamine in the corpus striatum and the limbic system publication-title: J Pharmacol – volume: 6 start-page: 371 year: 1979 end-page: 388 article-title: Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: validation of method publication-title: Ann Neurol – volume: 40 start-page: 179 year: 1997 end-page: 181 article-title: Labelling of lipophilic metabolite of [11C]raclopride and investigation of it's brain uptake in a Cynomolgus Monkey with PET publication-title: J Labelled Cpd Radiopharm – volume: 609 start-page: 237 year: 1993 end-page: 243 article-title: Identification of extrastriatal dopamine D receptors in post mortem human brain with [ I]epidepride publication-title: Brain Res – volume: 357 start-page: 146 year: 1990 end-page: 151 article-title: Molecular cloning and characterization of a novel dopamine receptor (D ) as a target for neuroleptics publication-title: Nature – volume: 35 start-page: 703 year: 1988 end-page: 707 article-title: Automated blood sampling systems for positron emission tomography publication-title: IEEE Trans Nucl Sci – volume: 5 start-page: 136 year: 1981 end-page: 141 article-title: Head fixation device for reproducible position alignment in transmission CT and positron emission tomography publication-title: J Comp Assist Tomogr – volume: 6 start-page: 461 year: 1978 end-page: 564 article-title: Estimating the dimension of a model publication-title: Ann Statist – volume: 103 start-page: 6 year: 1991 end-page: 18 article-title: NCQ 298, a new selective iodinated salicylamide ligand for the labelling of dopamine-D receptors publication-title: Psychopharmacol – volume: 261 start-page: 1282 year: 1992 end-page: 1290 article-title: Extrastriatal dopamine D receptors: distribution, pharmacological characterization and region-specific regulation by clozapine publication-title: J Pharmacol Exp Therapeutics – volume: 18 start-page: 110 year: 1994 end-page: 118 article-title: The ECAT EXACT HR: performance of a new high resolution positron scanner publication-title: J Comput Assist Tomogr – volume: 6 start-page: 137 year: 1986 end-page: 146 article-title: Quantification of neuroreceptors in the living human brain 1. Irreversible binding of ligands publication-title: J Cereb Blood Flow Metab – volume: 10 start-page: 740 year: 1990 end-page: 747 article-title: Graphical analysis of reversible radioligand binding from time-activity measurements applied to [n-11C-methyl]-(-)-cocaine PET studies in human subjects publication-title: J Cereb Blood Flow Metab – volume: 55 start-page: 33 year: 1994 end-page: 36 article-title: Neuroanatomical targets of neuroleptic drugs as revealed by Fos immunochemistry publication-title: J Clin Psychiatry – volume: 9 start-page: 696 year: 1989 end-page: 708 article-title: Kinetic analysis of central [ C]raclopri de binding to D -dopamine receptors studied by PET – a comparison to the equilibrium analysis publication-title: J Cereb Blood Flow Metab – volume: 36 start-page: 1275 year: 1995a end-page: 1281 article-title: Carbon-11-FLB 457: a radioligand for extrastriatal D2 dopamine receptors publication-title: J Nucl Med – volume: 91 start-page: 11271 year: 1994 end-page: 11275 article-title: Localization of dopamine D receptors to mesolimbic and D receptors to mesostriatal regions of human forebrain publication-title: Proc Natl Acad Sci USA – volume: 55 start-page: 79 year: 1991 end-page: 96 article-title: Psychosis and the temporal lobe publication-title: Adv Neurol – volume: 15 start-page: 568A year: 1992 end-page: 569A article-title: Mesoprefrontal cortical dopaminergic activity and prefrontal hypofunction in schizophrenia publication-title: Clin Neuropharmacol – volume: 19 start-page: 14 year: 1995 end-page: 17 article-title: Haloperidol blocks the uptake of [18F]N-methylspiroperidol by extrastriatal dopamine receptors in schizophrenic patients publication-title: Synapse – volume: 15 start-page: 643 year: 1995 article-title: Comparison of currently applied methods for PET quantification of specific [ C]raclopride binding publication-title: J Cereb Blood Flow Metab – volume: 82 start-page: 3863 year: 1985 end-page: 3867 article-title: Substituted benzamides as ligands for visualization of dopamine receptor binding in the human brain by positron emission tomography publication-title: Proc Natl Acad Sci USA – volume: 4 start-page: 153 year: 1996 end-page: 158 article-title: Simplified Reference Tissue Model for PET Receptor Studies publication-title: Neuroimage – volume: 564 start-page: 203 year: 1991 end-page: 219 article-title: Localization of dopamine-D receptor mRNA in the rat brain using hybridization histochemistry: comparison with dopamine-D receptor mRNA publication-title: Brain Res – volume: 128 start-page: 240 year: 1996b end-page: 247 article-title: Autoradiographic localization of D -dopamine receptors in the human brain using the selective D -dopamine receptor agonist [+)-[3H)PD 128097 publication-title: Psychopharmacol – volume: 23 start-page: 813 year: 1996 end-page: 819 article-title: Preparation of [ Br]FLB 457, [ Br]FLB 463 and for examination of striatal and extrastriatal dopamine D2 receptors with PET publication-title: Nucl Med Biol – volume: 16 start-page: 42 year: 1996 end-page: 52 article-title: Comparison of methods for analysis of clinical [ C]raclopride studies publication-title: J Cereb Blood Flow Metab – volume: 86 start-page: 6412 year: 1989 end-page: 6416 article-title: Dopamine D receptors in the cerebral cortex: Distribution and pharmacological characterization with [ H]raclopride publication-title: Proc Nat! Acad Sci USA – volume: 779 start-page: 58 year: 1998 end-page: 74 article-title: D3 dopamine receptor mRNA is widely expressed in the human brain publication-title: Brain Res – volume: 385 start-page: 634 year: 1997 end-page: 636 article-title: Decreased prefrontal dopamine D1-receptors in schizophrenia revealed by PET publication-title: Nature – volume: 221 start-page: 1264 year: 1983 end-page: 1266 article-title: Imaging dopamine receptors in the human brain by positron tomography publication-title: Science – volume: 11 start-page: 245 year: 1994 end-page: 256 article-title: Distribution of D - and D - dopamine receptors, and dopamine and its metabolites in the human brain publication-title: Neurpsychopharmacol – volume: 386 start-page: 830 year: 1997 end-page: 833 article-title: Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects publication-title: Nature – volume: 35 start-page: 161 year: 1976 end-page: 168 article-title: Antagonism of the hyperactivity induced by dopamine applied intracerebrally to nucleus accumbens septi by typical neuroleptics and by clozapine, sulpiride and thioridazine publication-title: Eur J Pharmacol – volume: 15 start-page: 217 year: 1984 end-page: 227 article-title: A quantitative model for the assessment of drug binding sites with positron emission tomography publication-title: Ann Neurol – volume: 20 start-page: 200 year: 1995 end-page: 208 article-title: Variability in D -dopamine receptor density and affinity: a PET-study with [ C]raclopride in man publication-title: Synapse – volume: 23 start-page: 115 year: 1996a end-page: 123 article-title: Autoradiographic localization of extrastriatal D -dopamine receptors in the human brain using [ I]epidepride publication-title: Synapse – volume: 19 start-page: 716 year: 1974 end-page: 723 article-title: A new look at the statistical model identification publication-title: IEEE Trans Automat Contr – volume: 133 start-page: 396 year: 1997b end-page: 404 article-title: A pet study of [C-11)FLB 457 binding to extrastriatal D2-dopamine receptors in healthy subjects and antipsychotic drug-treated patients publication-title: Psychopharmacology – volume: 18 start-page: 187 year: 1993 end-page: 192 article-title: Dopamine-D3 receptor messenger RNA and binding sites in human brain publication-title: Mol Brain Res – volume: 385 start-page: 590 year: 1997a article-title: D -dopamine receptors and personality traits publication-title: Nature – volume: 20 start-page: 60 year: 1999 end-page: 80 article-title: Distribution of dopamine D3 receptor expressing neurons in the human forebrain: comparison with D2 receptor expressing neurons publication-title: Neuropsychopharmacol – ident: bibr18-00004647-199910000-00013 doi: 10.1007/s002130050131 – volume: 15 start-page: 643 year: 1995 ident: bibr35-00004647-199910000-00013 publication-title: J Cereb Blood Flow Metab – ident: bibr2-00004647-199910000-00013 doi: 10.1111/j.2042-7158.1973.tb10025.x – ident: bibr17-00004647-199910000-00013 doi: 10.1002/(SICI)1098-2396(199606)23:2<115::AID-SYN7>3.0.CO;2-C – ident: bibr27-00004647-199910000-00013 doi: 10.1097/00004647-199601000-00005 – volume-title: PET Pharmacokinetic Course. year: 1997 ident: bibr29-00004647-199910000-00013 – volume: 261 start-page: 1282 year: 1992 ident: bibr23-00004647-199910000-00013 publication-title: J Pharmacol Exp Therapeutics – ident: bibr45-00004647-199910000-00013 doi: 10.1097/00002826-199201001-00296 – ident: bibr49-00004647-199910000-00013 doi: 10.1002/syn.890190103 – ident: bibr13-00004647-199910000-00013 doi: 10.1002/syn.890200303 – ident: bibr22-00004647-199910000-00013 doi: 10.1007/978-94-011-0429-6_5 – ident: bibr33-00004647-199910000-00013 doi: 10.1002/ana.410150302 – ident: bibr34-00004647-199910000-00013 doi: 10.1073/pnas.91.23.11271 – ident: bibr37-00004647-199910000-00013 doi: 10.1002/ana.410060502 – ident: bibr31-00004647-199910000-00013 doi: 10.1016/0969-8051(96)00078-9 – ident: bibr24-00004647-199910000-00013 doi: 10.1016/0006-8993(93)90878-Q – ident: bibr48-00004647-199910000-00013 doi: 10.1038/jcbfm.1986.27 – ident: bibr44-00004647-199910000-00013 doi: 10.1126/science.6604315 – ident: bibr19-00004647-199910000-00013 doi: 10.1007/BF02244067 – volume: 55 start-page: 33 year: 1994 ident: bibr15-00004647-199910000-00013 publication-title: J Clin Psychiatry – ident: bibr8-00004647-199910000-00013 doi: 10.1016/0306-4522(95)00357-6 – ident: bibr38-00004647-199910000-00013 – ident: bibr11-00004647-199910000-00013 doi: 10.1038/jcbfm.1989.98 – ident: bibr1-00004647-199910000-00013 doi: 10.1109/TAC.1974.1100705 – ident: bibr30-00004647-199910000-00013 doi: 10.1073/pnas.86.16.6412 – ident: bibr28-00004647-199910000-00013 doi: 10.1016/0169-328X(93)90188-U – ident: bibr3-00004647-199910000-00013 doi: 10.1097/00004728-198102000-00027 – ident: bibr42-00004647-199910000-00013 doi: 10.1016/S0006-8993(97)01078-0 – ident: bibr14-00004647-199910000-00013 doi: 10.1007/s002130050420 – ident: bibr32-00004647-199910000-00013 doi: 10.1038/jcbfm.1990.127 – ident: bibr5-00004647-199910000-00013 doi: 10.1016/S0166-2236(84)80013-2 – ident: bibr39-00004647-199910000-00013 doi: 10.1214/aos/1176344136 – volume: 40 start-page: 179 year: 1997 ident: bibr43-00004647-199910000-00013 publication-title: J Labelled Cpd Radiopharm – ident: bibr16-00004647-199910000-00013 doi: 10.1016/S0893-133X(98)00066-9 – ident: bibr10-00004647-199910000-00013 doi: 10.1073/pnas.82.11.3863 – volume: 36 start-page: 1275 year: 1995 ident: bibr21-00004647-199910000-00013 publication-title: J Nucl Med – ident: bibr9-00004647-199910000-00013 doi: 10.1109/23.12815 – volume: 55 start-page: 79 year: 1991 ident: bibr41-00004647-199910000-00013 publication-title: Adv Neurol – ident: bibr26-00004647-199910000-00013 doi: 10.1006/nimg.1996.0066 – ident: bibr46-00004647-199910000-00013 doi: 10.1097/00004728-199401000-00023 – volume: 24 start-page: 483 year: 1997 ident: bibr25-00004647-199910000-00013 publication-title: Eur J Nucl Med – ident: bibr12-00004647-199910000-00013 doi: 10.1038/385590a0 – ident: bibr7-00004647-199910000-00013 doi: 10.1176/ajp.148.11.1474 – ident: bibr36-00004647-199910000-00013 doi: 10.1038/385634a0 – ident: bibr20-00004647-199910000-00013 doi: 10.1038/sj.npp.1380111 – ident: bibr40-00004647-199910000-00013 doi: 10.1038/347146a0 – ident: bibr4-00004647-199910000-00013 doi: 10.1016/0006-8993(91)91456-B – ident: bibr6-00004647-199910000-00013 doi: 10.1016/0014-2999(76)90311-3 – ident: bibr47-00004647-199910000-00013 doi: 10.1038/386830a0 |
SSID | ssj0008355 |
Score | 2.0076058 |
Snippet | Positron emission tomography (PET) has hitherto been used to examine D2 dopamine receptor binding in the striatum, a region with a high density of receptors.... |
SourceID | swepub pubmed pascalfrancis crossref sage |
SourceType | Open Access Repository Index Database Enrichment Source Publisher |
StartPage | 1164 |
SubjectTerms | Adult Binding Sites Biological and medical sciences Carbon Radioisotopes Cerebellum - chemistry Cerebellum - metabolism Dopamine Antagonists Humans Investigative techniques, diagnostic techniques (general aspects) Kinetics Male Medical sciences Nervous system Putamen - chemistry Putamen - metabolism Pyrrolidines Radiodiagnosis. Nmr imagery. Nmr spectrometry Receptors, Dopamine D2 - metabolism Reference Standards Salicylamides Temporal Lobe - chemistry Temporal Lobe - metabolism Thalamus - chemistry Thalamus - metabolism Tomography, Emission-Computed - methods Tomography, Emission-Computed - standards |
Title | Quantification of [11C]FLB 457 Binding to Extrastriatal Dopamine Receptors in the Human Brain |
URI | https://journals.sagepub.com/doi/full/10.1097/00004647-199910000-00013 https://www.ncbi.nlm.nih.gov/pubmed/10532641 http://kipublications.ki.se/Default.aspx?queryparsed=id:1927724 |
Volume | 19 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwGLXKeAAJIdi4DBjyA9tLlSlO4rh-XLt1FUJIiCJVQiiyE0dMpGnVpuLy4_htfL7kUhii7CWKEsVN-p34O46Pz4fQK8oDJSFNwCvuCy8ayMDjPMo8PpBAJ_wQMqZx-3wbTz5Er2d01uv97KiWNpU8TX9cu67kJlGFYxBXvUr2PyLbNAoHYB_iC1uIMGx3ivG7jbBan4b3HdNhn5D-6Jiej98M-xFl_eGVXbgCJPPiW7USplCHXgJ5DuPluSaZQB3V0lTdcaJH-2V_qKtH_IW8pmqlZ5wLK3zv58XCKovnqgJUFbUvofl6u3aLuiaiXLcdXqFnvVp7g1Yk_P6r-Fw6LUrhXQLBFs25MeDZVoYWq84HC2NyUEvf6n4tYMSDHDmzKcj1u5R7zLfLLpuOmXcB6He6WUKs9blL2YTYcih_pANrM2zGQXHEtKiGm_kMz1DfNgXW0_6_ZcZGr9iZqTctJU1LZvI-vIVuB4wZmcDlrJUYAbs1Etr6gZ2SrDYNve6etujRvaVYw5ua2xIrHY7kHCG2zG0NIZo-QPcdGPCZheVD1FPlPjo4K0W1mH_HJ9hoi82kzT66M6rrCh6gZBu1eJHjj5gQPPoEiMWAWOwQi6sF3kIsrhGLG8TiqxIDYrFBLDaIfYSm44vpaOK5Mh9eGlFeeVSoHIYlkZQ8i5jQBoWB0MaWXLJMMSLyVKhIxBzYaqakn4WZkDIb5CnQUz8NH6O9clGqpwhnYawoFalMpYoCP-U0UCHPgjTQ4xJBDhGr_9wkdRb4uhJLkfwrwIeINFcurQ3MDtccbcWvvZDHgc_h_BMbz06LFEZTEdznqQ5w4rqa9Q4_dWKh0DSlXePdoS-wp5LYDwcxe3aD53iO7rav8Qu0V6026giYeCVfGrj_AkRiyzs |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Quantification+of+%5B+11+C%5DFLB+457+Binding+to+Extrastriatal+Dopamine+Receptors+in+the+Human+Brain&rft.jtitle=Journal+of+cerebral+blood+flow+and+metabolism&rft.au=Olsson%2C+Hans&rft.au=Halldin%2C+Christer&rft.au=Swahn%2C+Carl-Gunnar&rft.au=Farde%2C+Lars&rft.date=1999-10-01&rft.issn=0271-678X&rft.eissn=1559-7016&rft.volume=19&rft.issue=10&rft.spage=1164&rft.epage=1173&rft_id=info:doi/10.1097%2F00004647-199910000-00013&rft.externalDBID=n%2Fa&rft.externalDocID=10_1097_00004647_199910000_00013 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0271-678X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0271-678X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0271-678X&client=summon |